Wang, Erjian http://orcid.org/0000-0002-4729-7564
DuBois, Steven G.
Wetmore, Cynthia
Khosravan, Reza
Funding for this research was provided by:
Pfizer
Article History
Received: 4 March 2020
Accepted: 24 June 2020
First Online: 4 July 2020
Compliance with ethical standards
:
: Erjian Wang and Reza Khosravan are employees of Pfizer and hold stock or stock options with Pfizer. Steven G. DuBois has received prior travel expenses from Loxo Oncology, Roche and Salarius, and prior consulting fees from Loxo Oncology. Cynthia Wetmore has received research support and prior travel expenses from Eli Lilly & Co.
: The original trials were approved by the institutional review boards at all participating centers. The National Cancer Institute Pediatric Central institutional review board also approved study ACNS1021.
: All participants in the original trials or their parent/legal guardian signed a document of informed consent and assent was obtained as appropriate.